Stefani Spranger on Immunotherapy Versus Chemotherapy

Video

In Partnership With:

Stefani Spranger, PhD, postdoctoral fellow, Cancer Research Institute at The University of Chicago, discusses the differences between immunotherapy and chemotherapy.

Stefani Spranger, PhD, postdoctoral fellow, Cancer Research Institute at The University of Chicago, discusses the differences between immunotherapy and chemotherapy.

With chemotherapy, any proliferating cell is targeted and will die. Immuooncology takes a very different approach, says Spranger, because the immune system is for specific at recognizing what the malfunctioning cells are and only killing those cells.

Another big difference is the immune system does have a memory and this memory plays out for the long-term, she says. If a drug is able to active the immune system to recognize that one particular cancer, the cancer will not be forgotten. When there is a recurrence, the immune system will still be able to recognize the same cancer and still be able to fight it.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD